Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation

Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation

Bibliographic Details
Main Authors:	Matza, Louis S, Phillips, Glenn A, Revicki, Dennis A, Ascher-Svanum, Haya, Malley, Karen G, Palsgrove, Andrew C, Faries, Douglas E, Stauffer, Virginia, Kinon, Bruce J, Awad, A George, Keefe, Richard SE, Naber, Dieter
Format:	Online
Language:	English
Published:	Dove Medical Press 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413072/

Similar Items

Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients’ and clinicians’ perspectives in a clinical trial
by: Faries, Douglas, et al.
Published: (2012)

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
by: Ascher-Svanum, Haya, et al.
Published: (2006)

Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy
by: Peng, Xiaomei, et al.
Published: (2011)

Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia
by: Ascher-Svanum, Haya, et al.
Published: (2005)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
by: Faries, Douglas, et al.
Published: (2005)

Reasons for continuing or discontinuing olanzapine in the treatment of schizophrenia from the perspectives of patients and clinicians
by: Chen, Jian, et al.
Published: (2011)

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia
by: Ascher-Svanum, Haya, et al.
Published: (2012)

The longitudinal interplay between negative and positive symptom trajectories in patients under antipsychotic treatment: a post hoc analysis of data from a randomized, 1-year pragmatic trial
by: Chen, Lei, et al.
Published: (2013)

Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients
by: Ascher-Svanum, Haya, et al.
Published: (2009)

Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia
by: Peng, Xiaomei, et al.
Published: (2011)

The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trial
by: Chen, Lei, et al.
Published: (2011)

The heterogeneity of antipsychotic response in the treatment of schizophrenia
by: Case, M., et al.
Published: (2011)

A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia
by: Ascher-Svanum, Haya, et al.
Published: (2004)

Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics
by: Liu-Seifert, Hong, et al.
Published: (2011)

Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan
by: Ye, Wenyu, et al.
Published: (2012)

Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis
by: Ye, Wenyu, et al.
Published: (2012)

Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia
by: Chen, Lei, et al.
Published: (2013)

Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study
by: Haynes, Virginia S, et al.
Published: (2012)

The personal, societal, and economic burden of schizophrenia in the People’s Republic of China: implications for antipsychotic therapy
by: Montgomery, William, et al.
Published: (2013)

One-year outcomes in schizophrenia after switching from typical antipsychotics to olanzapine in Japan: an observational study
by: Ye, Wenyu, et al.
Published: (2012)

Early Discontinuation and Restart of Insulin in the Treatment of Type 2 Diabetes Mellitus
by: Ascher-Svanum, Haya, et al.
Published: (2014)

Every reason to discontinue lithium
by: Salgado, Manuel E Fuentes, et al.
Published: (2014)

Sustained favorable long-term outcome in the treatment of schizophrenia: a 3-year prospective observational study
by: Cuyún Carter, Gebra B, et al.
Published: (2011)

Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs
by: Liu-Seifert, Hong, et al.
Published: (2005)

The Fatigue Associated with Depression Questionnaire (FAsD): responsiveness and responder definition
by: Matza, Louis S., et al.
Published: (2012)

Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence
by: Kelin, Katarina, et al.
Published: (2011)

Reasons given by mothers for discontinuing breastfeeding in Iran
by: Olang, Beheshteh, et al.
Published: (2012)

The comparison of glucose and lipid metabolism parameters in drug-naïve, antipsychotic-treated, and antipsychotic discontinuation patients with schizophrenia
by: Wu, Xiaoli, et al.
Published: (2014)

Management of antipsychotic treatment discontinuation and interruptions using model-based simulations
by: Samtani, Mahesh N, et al.
Published: (2012)

Second-Generation Antipsychotic Discontinuation in First Episode Psychosis: An Updated Review
by: Miller, Brian J., et al.
Published: (2011)

Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan
by: Ye, Wenyu, et al.
Published: (2011)

Item response analysis of the Positive and Negative Syndrome Scale
by: Santor, Darcy A, et al.
Published: (2007)

Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons
by: Ascher-Svanum, Haya, et al.
Published: (2012)

Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment
by: Gameiro, S., et al.
Published: (2012)

Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties
by: Montgomery, William, et al.
Published: (2012)

Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection: post hoc analysis of a randomized, double-blind study
by: Ascher-Svanum, Haya, et al.
Published: (2013)

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
by: Ascher-Svanum, Haya, et al.
Published: (2014)

Characteristics of patients misdiagnosed with Alzheimer’s disease and their medication use: an analysis of the NACC-UDS database
by: Gaugler, Joseph E, et al.
Published: (2013)

Empirically driven definitions of “good,” “moderate,” and “poor” levels of functioning in the treatment of schizophrenia
by: Ascher-Svanum, Haya, et al.
Published: (2012)

Schizophrenia Outpatient Health Outcomes study: twelve-month findings
by: Novick, Diego, et al.
Published: (2012)